Última revisão: 6 Nov 2021
Última atualização: 24 Nov 2020

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • tosse
  • doença semelhante à gripe (influenza)
  • dispneia
  • febre
  • estertores, roncos
  • sibilo
  • murmúrios vesiculares reduzidos
  • taquipneia

Outros fatores diagnósticos

  • dor abdominal, vômitos, diarreia
  • estado mental alterado
  • convulsões

Fatores de risco

  • contato próximo com aves infectadas
  • viagem recente a um país no qual se relataram casos de infecção pelo vírus H5N1 da IAAP
  • exposição ambiental ao vírus H5N1
  • contato próximo com humanos infectados
  • rotina laboratorial com o vírus H5N1

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • Hemograma completo com diferencial
  • TFHs
  • radiografia torácica
  • oximetria de pulso
  • coloração de Gram de expectoração
  • cultura bacteriana do sangue e do escarro
  • reação em cadeia da polimerase via transcriptase reversa (RT-PCR) de amostras respiratórias

Novos exames

  • teste sorológico para anticorpo específico do H5N1 para diagnóstico retrospectivo

Algoritmo de tratamento

Colaboradores

Autores

Justin R. Ortiz, MD, MS

Affiliate Assistant Professor of Medicine & Global Health

University of Washington

Seattle

WA

Declarações

JRO received honorarium from Pfizer for speaking on adult immunisation policies at the 2019 Immunisation for All Ages Summit and participation on the Immunisation for All Ages Steering Group. JRO has participated on the Global Influenza Hospital Surveillance Network for Sanofi and has received honorarium from the International Federation on Aging for speaking about adult immunisation policies at the 2019 United Nations International Day of Older Persons side event “End Immunisation Inequality Toward Healthy Aging”. JRO receives research grants and contracts to evaluate influenza vaccines from the National Institutes of Health and has served as a medical monitor for a cholera vaccine study for Pharmaron.

Timothy M. Uyeki, MD, MPH, MPP

Chief Medical Officer

Influenza Division

National Center for Immunization and Respiratory Diseases

Centers for Disease Control and Prevention

Atlanta

GA

Declarações

TMU declares that he has no competing interests.

Revisores

Waleed Javaid, MD, FACP, FIDSA

Associate Professor

Medical Director of Infection Control

Infectious Disease

Department of Medicine

SUNY Upstate Medical University

Syracuse

NY

Declarações

WJ declares that he has no competing interests.

An De Sutter, MD, PhD

Associate Professor

Department of General Practice and Primary Health Care

Ghent University

Belgium

Declarações

ADS declares that she has no competing interests.

Nayer Khazeni, MD, MS

Assistant Professor

Pulmonary & Critical Care Medicine

Associate

Center for Health Policy/Center for Primary Care & Outcomes Research

Stanford University School of Medicine

Stanford

CA

Declarações

NK declares that she has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal